(6beta)-Matridin-15-one(CAS: 641-39-4)

(6beta)-Matridin-15-one (CAS: 641-39-4) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and is subject to the European Chemicals Agency’s (ECHA) REACH regulations. In the USA, it must comply with the regulations of the FDA and EPA. Users should consult the Material Safety Data Sheet (MSDS) and the manufacturer’s guidelines for specific handling and storage instructions.

Several alternatives to (6beta)-Matridin-15-one can be used in synthesis, such as isomers or analogs like (6alpha)-Matridin-15-one or (6gamma)-Matridin-15-one. Common alternative reagents include citral and geraniol. These alternatives can provide similar functionalities and can be chosen based on the specific requirements and availability.

(6beta)-Matridin-15-one (CAS: 641-39-4) is primarily researched for its potential in natural product chemistry and pharmaceutical applications. Market trends indicate increasing interest in its use as a precursor in the synthesis of bioactive compounds. Recent studies focus on its role in anti-inflammatory and antimicrobial activities, with ongoing exploration into its therapeutic potential in various diseases.

Waste containing (6beta)-Matridin-15-one (CAS: 641-39-4) should be handled according to local waste disposal regulations. Collect waste liquids in appropriate containers and ensure proper incineration or professional waste disposal to minimize environmental impact. Always wear appropriate personal protective equipment (PPE) and follow safety guidelines to avoid exposure. Environmental protection precautions include neutralizing acids or bases in the waste before disposal to prevent chemical reactions and potential hazards.